Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tramadol in palliative care #290.

Jennifer Pruskowski, Robert M Arnold

    Journal of Palliative Medicine
    |April 29, 2015
    PubMed
    Summary

    Tramadol is a Step II WHO pain ladder agent effective for mild to moderate pain. However, dosing, side effects, and interactions may limit its long-term use for severe pain management.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Feasibility of Safe and Efficient Administration of COVID-19 Chemoprophylaxis to Nursing Home Residents.

    Journal of the American Medical Directors Association·2025
    Same author

    Course Development and Integration of a Skills-Based Assessment for an Elective Palliative Care Course.

    American journal of pharmaceutical education·2025
    Same author

    Impact of a family support intervention on hospitalization costs and hospital readmissions among ICU patients at high risk of death or severe functional impairment.

    Annals of intensive care·2024
    Same author

    Artificial intelligence for better goals of care documentation.

    BMJ supportive & palliative care·2024
    Same author

    Fast Facts and Concepts #485 Developing a Shared "Headline" before a Family Meeting.

    Journal of palliative medicine·2024
    Same author

    Equity in Using Artificial Intelligence Mortality Predictions to Target Goals of Care Documentation.

    Journal of general internal medicine·2024

    Area of Science:

    • Pharmacology
    • Pain Management
    • Clinical Therapeutics

    Background:

    • Tramadol is a widely used analgesic.
    • It is classified as a Step II agent on the World Health Organization (WHO) pain ladder.
    • Effective for mild to moderate pain intensity across various syndromes.

    Purpose of the Study:

    • To evaluate the efficacy and limitations of Tramadol.
    • To discuss factors influencing its chronic use.
    • To provide a comprehensive overview of Tramadol's role in pain management.

    Main Methods:

    • Literature review of Tramadol's pharmacological profile.
    • Analysis of clinical guidelines and studies on pain management.
    • Examination of adverse drug reactions and drug interactions.

    Main Results:

    • Tramadol demonstrates efficacy in managing mild to moderate pain.
    • Potential limitations include dosing adjustments, ceiling effect, and cost.
    • Significant adverse drug reactions and drug interactions are noted.

    Conclusions:

    • Tramadol serves a crucial role in Step II pain management.
    • Its chronic use may be restricted by several factors.
    • Careful consideration of benefits versus risks is essential for patient care.

    Related Experiment Videos